Acurx Pharmaceuticals (ACXP)
NASDAQ:ACXP
Holding ACXP?
Track your performance easily

Acurx Pharmaceuticals (ACXP) Stock Investors

118 Followers
Based on 757,311 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold ACXP
On average, investors allocate 0.00% of their portfolios to ACXP
The average holding size of this company in investors' portfolios.

Investor Sentiment

Neutral
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 757,311 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding ACXP

1.7%
Last 7
Days
2.2%
Last 30
Days
Percentages indicate the change in the number of portfolios holding ACXP, out of 757,311 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

ACXP Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
0.97%
$2.26
Opened
0.01%
$1.87
Based on the activity of 14,468 investors who made their portfolios public
The table shows changes in ACXP in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

ACXP Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Riot Platforms
4.72%
-1.32%
-1.97%
2.18B
Financial
Blink Charging Co
5.32%
-1.73%
-3.80%
183.08M
Industrials
Block
4.24%
-1.24%
-2.76%
41.09B
Technology
Coherus Biosciences
2.45%
+0.17%
-1.13%
120.97M
Healthcare
Merck & Company
3.78%
-0.87%
+1.02%
300.73B
Healthcare
RTX
4.24%
-1.28%
-0.76%
157.02B
Industrials
Devon Energy
5.08%
-0.79%
-0.79%
25.28B
Energy
Cisco Systems
4.41%
-1.30%
-0.68%
201.81B
Technology
Airbnb
4.28%
-0.79%
+1.41%
78.68B
Consumer Cyclical
3M
5.62%
-1.11%
-0.62%
73.26B
Industrials
Based on the activity of 757,311 active portfolios
Open your Smart Portfolio

ACXP Investor Analysis

ACXP investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
16.7%
of ACXP holders
are under 35
Average Segment Performance
Average P/E Ratio20.16
Beta8.32
Dividend Yield3.50%
ACXP investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
41.7%
of ACXP holders
are between 35–55
Average Segment Performance
Average P/E Ratio18.25
Beta13.76
Dividend Yield3.65%
ACXP investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
41.7%
of ACXP holders
are over 55
Average Segment Performance
Average P/E Ratio20.06
Beta4.95
Dividend Yield3.36%
Overview of age group and performance of ACXP stock investors
See who invests in ACXP according to age group and performance.

FAQ

How many retail Investors hold ACXP?
<0.1% of TipRanks' retail investors hold ACXP in their portfolios.
    What is ACXP Investor Sentiment?
    ACXP’s Investor Sentiment is Neutral.
      What percentage of retail investors changed their holding of ACXP in the last 7 days?
      ▼ 1.7% of TipRanks' retail investors changed their holding of ACXP in the last 7 days.
        What percentage of retail investors changed their holding of ACXP in the last 30 days?
        ▲ 2.2% of TipRanks' retail investors changed their holding of ACXP in the last 30 days.
          What is the average age of retail investors who hold ACXP?
          The average age of ACXP Holders is over 55.
            What other stocks have ACXP investors also bought?
            ACXP Investors also bought RIOT, BLNK, SQ, CHRS, MRK, RTX, DVN, CSCO, ABNB, MMM.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              BMRNBioMarin Pharmaceutical
              BSXBoston Scientific
              CPRXCatalyst Pharma
              EXELExelixis
              AVDLAvadel Pharmaceuticals
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis